Mrowietz, U; Sommer, R; Reguiai, Z; Gerdes, S; Dauden, E; Weger, W; Maul, JT; Laws, P; Naldi, L; Ghislain, PD; de Jong, E; Mburu, S; Koscielny, V; Massana, E; Kasujee, I; Kirsch, A; Augustin, M.
High efficacy of tildrakizumab regardless of baseline characteristics in patients with moderate to severe plaque psoriasis: Interim results of the POSITIVE study at week 52
J DTSCH DERMATOL GES. 2025; 23:
Web of Science